Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Mice lacking cyclophilin B, but not cyclophilin A, are protected from the development of NASH in a diet and chemical-induced model.
PLoS One. 2024 Mar 1;19(3):e0298211. doi: 10.1371/journal.pone.0298211. eCollection 2024.
PLoS One. 2024.
PMID: 38427624
Free PMC article.
The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity.
Stauffer W, Bobardt M, Ure D, Foster R, Gallay P.
Stauffer W, et al.
Viruses. 2023 Oct 17;15(10):2099. doi: 10.3390/v15102099.
Viruses. 2023.
PMID: 37896876
Free PMC article.
Item in Clipboard
The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity.
Stauffer W, Bobardt M, Ure D, Foster R, Gallay P.
Stauffer W, et al.
bioRxiv [Preprint]. 2023 Aug 20:2023.08.19.553982. doi: 10.1101/2023.08.19.553982.
bioRxiv. 2023.
PMID: 37645728
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma.
Simón Serrano S, Tavecchio M, Mallik J, Grönberg A, Elmér E, Kifagi C, Gallay P, Hansson MJ, Massoumi R.
Simón Serrano S, et al.
Cancers (Basel). 2022 Sep 20;14(19):4553. doi: 10.3390/cancers14194553.
Cancers (Basel). 2022.
PMID: 36230472
Free PMC article.
Item in Clipboard
The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance.
Bobardt M, Ramirez CM, Baum MM, Ure D, Foster R, Gallay PA.
Bobardt M, et al.
PLoS One. 2021 May 20;16(5):e0251934. doi: 10.1371/journal.pone.0251934. eCollection 2021.
PLoS One. 2021.
PMID: 34014993
Free PMC article.
Item in Clipboard
Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice.
Bobardt M, Hansson MJ, Mayo P, Ure D, Foster R, Gallay P.
Bobardt M, et al.
PLoS One. 2020 Aug 7;15(8):e0237236. doi: 10.1371/journal.pone.0237236. eCollection 2020.
PLoS One. 2020.
PMID: 32764799
Free PMC article.
Item in Clipboard
Cite
Cite